Life at OSU

In a study of proteins historic in its scope, researchers have pushed closer both to a vaccine for gonorrhea and toward understanding why the bacteria that cause the disease are so good at fending off antimicrobial drugs.

Oregon State University researchers studying cervical cancer have identified a bacterium that helps the disease spread, a discovery that could open up a new way of treating cervical and other cancers.

Nanofiber-based wound dressings loaded with vitamin D spur the production of an antimicrobial peptide, a key step forward in the battle against surgical site infections, or SSIs.

PORTLAND, Ore. – Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients

Oregon State University Provost and Executive Vice President Ed Feser has announced that Mark Leid, a professor and associate dean for research in the College of Pharmacy, will serve as interim dean of the college effective July 1.

Researchers have learned that precursor cells for skeletal muscles actually also give rise to neurons, blood vessels, blood cells and immune cells, pushing science one step closer to generating body parts in a laboratory.

Meadowfoam, a native Pacific Northwest plant cultivated as an oilseed crop, has emerged as a potential new source of protection against the sun’s harmful effects on the skin.

Researchers have created new nanomaterials able to cross cell membranes, establishing a novel platform for the intracellular delivery of molecular drugs and other cargo.

Researchers are paving the way toward a new therapeutic approach for gonorrhea by shedding light on the mechanism behind important proteins on the Neisseria gonorrhoeae bacteria’s outer membrane.